全球經導管主動脈瓣置換術 (TAVR) 市場 - 市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033 年）

經導管主動脈瓣置換術適用於老年患者和嚴重症狀的主動脈瓣狹窄且手術風險較高的患者。 由於人口結構的變化，主動脈瓣狹窄患者的數量正在穩定增加。 雖然主動脈瓣置換術仍然是黃金標準治療，但經導管主動脈瓣置換術（也稱為經導管主動脈瓣植入術）是不能手術的老年患者和手術風險高的患者的一種替代療法。其作為手術主動脈瓣植入術的替代方案的適用性正在研究中。由於其手術和恢復時間短而受到研究。

本報告研究和分析了全球經導管主動脈瓣置換術 (TAVR) 市場，並提供了有關每個細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 影響的資訊。

市場模型的主要內容如下。

已上市的經導管主動脈瓣置換術 (TAVR) 和不斷變化的競爭格局

• 對主要產業趨勢的考慮
• 經導管主動脈瓣置換術 (TAVR) 市場年收入和市場前景（按細分市場）（2015-2033 年）
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

• 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
• 經導管主動脈瓣置換術 (TAVR) 市場的 SWOT 分析
• 經導管主動脈瓣置換術 (TAVR) 市場競爭動態的考量與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技監理狀況

目標公司

• Edwards Lifesciences
• Medtronic Plc
• Abbott Laboratories
• Boston Scientific Corp
• MicroPort Scientific Corp
• 其他

Abstract

Transcatheter Aortic Valve Replacement (TAVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Transcatheter Aortic Valve Replacement (TAVR) market for the year 2020 and beyond. Transcatheter aortic valve implantation is used in patients who are elderly or are at a high risk for surgery and have severe symptomatic aortic valve stenosis. The number of patients who suffer from aortic stenosis is steadily increasing due to changing demographics. While aortic valve replacement remains the gold standard therapy, transcatheter aortic valve Replacement, also known as transcatheter aortic valve implantation has been identified as an alternative in elderly patients, inoperable or of higher surgical risk, and its suitability as a replacement for surgical aortic valve implantation is being explored due to lower operation and recovery times. Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitonol stent. These valves can be either balloon expandable or self expandable.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Aortic Valve Replacement Devices (TAVR) and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Aortic Valve Replacement (TAVR) Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Aortic Valve Replacement (TAVR) Devices market.
• Competitive dynamics insights and trends provided for Transcatheter Aortic Valve Replacement (TAVR) Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Edwards Lifesciences, Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, MicroPort Scientific Corp, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Aortic Valve Replacement (TAVR) Systems marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Transcatheter Aortic Valve Replacement (TAVR) market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Aortic Valve Replacement (TAVR) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Aortic Valve Replacement (TAVR) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Aortic Valve Replacement (TAVR) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable